Inactive Instrument

Highlights Alopexx, Inc.

Equities

Alopexx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
Alopexx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	12-27	CI
Alopexx to Present Data on F598, a Novel, Broad-Spectrum Immunotherapeutic at IDWeek 2023	12/10/23	CI
Alopexx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18/11/22	CI
Alopexx, Inc. has filed an IPO in the amount of $18.328125 million.	04/03/22	CI

No results for this search